Short answer · Medically reviewed summary · Last updated: 2026-04-07
Susac syndrome was first described in 1979 by Dr. John O.
Susac syndrome was first described in 1979 by Dr. John O. Susac as a rare microangiopathy characterized by the clinical triad of encephalopathy, branch retinal artery occlusions (BRAO), and sensorineural hearing loss. Since its discovery, advancements in neuroimaging and immunology have shifted the understanding of Susac syndrome from a mysterious, often misdiagnosed condition to a recognized autoimmune disorder involving the small blood vessels of the brain, retina, and inner ear.
The condition was first identified in 1979 by American neurologist Dr. John O. Susac. He observed two young women presenting with a unique combination of symptoms that did not fit existing neurological diagnoses of the time. Originally, it was termed "retinocochleocerebral vasculopathy." It was not until 1986 that the medical community adopted the eponymous name Susac syndrome to honor the physician who first synthesized these disparate clinical findings into a cohesive diagnostic entity.
Early in its history, Susac syndrome was frequently misdiagnosed as Multiple Sclerosis (MS) or Acute Disseminated Encephalomyelitis (ADEM) because of the brain lesions visible on early MRI scans. As imaging technology improved—specifically the transition from standard MRI to high-resolution 3T MRI—clinicians began to notice the hallmark "snowball" lesions in the corpus callosum, which are highly specific to Susac syndrome. Research has now shifted from viewing it as a primary inflammatory disease to understanding it as an autoimmune-mediated endotheliopathy, where the body’s immune system mistakenly attacks the endothelium (the lining of small blood vessels).
For decades, many patients were mistakenly treated for MS with interferon-beta, which is ineffective and potentially harmful for those with Susac syndrome. Because the disease is so rare, patients often spent years visiting ophthalmologists, audiologists, and neurologists separately, failing to realize the symptoms were connected. Correcting these misconceptions required the development of interdisciplinary diagnostic criteria, which now mandate that clinicians look for the classic "triad" of symptoms:
The rise of digital patient communities, including the 20 members of the DiseaseMaps.org platform who have shared their experiences, has been transformative. Historical medical literature often focused on isolated case reports, but modern patient advocacy has allowed for the aggregation of data that helps researchers understand the natural history of Susac syndrome. This collective knowledge has empowered patients to advocate for earlier testing, such as fluorescein angiography, which is critical for identifying the retinal artery occlusions that confirm a Susac syndrome diagnosis.
Medical Disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.